What is Novavax, Inc. (NVAX)?
Novavax, Inc. (NVAX) is a stock traded on Cboe One and quoted in USD. The company is a biotechnology firm best known for developing vaccines, including protein-based candidates aimed at infectious diseases. As a publicly listed equity, its shares can be bought and sold by investors seeking exposure to the biotech sector. On TradeSearcher, Novavax has been put through more than 1,900 backtests, drawing on price data reaching back to 1995.